Signature Global, IndusInd Bank, Pharma Stocks: Key Market Moves
Signature Global said it awarded ₹920 crore construction contracts for its Sarvam at DXP Estate in Gurugram, with KEC International and NCC building 11 towers and 1,798 units. IndusInd Bank received RBI approval to form a wholly-owned stockbroking subsidiary. Novartis India will end its Dr. Reddy’s distribution deal from Sep 30, 2026. Emcure Pharma got USFDA closure for its Sanand facility, AstraZeneca Pharma India gained approval for Enhertu. NTPC Green Energy won a battery storage project and






